Señales en vivo de NTEC | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (31 dic 1970 @ 19:00):

Intec Pharma Ltd, a clinical stage biopharmaceutical company, focuses on developing drugs based on its proprietary Accordion Pill platform technology in Israel...

Stats
Volumen de hoy	988 303
Volumen promedio	1.05M
Capitalización de mercado	0.00
EPS	$0 ( 2021-08-04 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0.345 (3.58%)

Insider Trading

Date	Person	Action	Amount	type
2021-07-23	Hayes William B	Sell	250	Stock Option (right to buy)
2021-07-23	Hayes William B	Sell	250	Stock Option (right to buy)
2021-07-23	Hayes William B	Sell	500	Stock Option (right to buy)
2021-07-23	Karah Hila	Sell	281	Stock Option (right to buy)
2021-07-23	Karah Hila	Sell	250	Stock Option (right to buy)

INSIDER POWER
0.00
Last 59 transactions
Buy: 3 599 185 \| Sell: 7 817 315

Volumen Correlación

Largo: 0.44 (neutral)

Corto: 0.85 (strong)

Signal:(64.456) Same movement expected

Intec Pharma Ltd Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Intec Pharma Ltd Correlación - Moneda/Commodity

0.42
( neutral )

0.46
( neutral )

-0.20
( neutral )

0.28
( neutral )

-0.54
( weak negative )

-0.32
( neutral )

Intec Pharma Ltd Finanzas

Annual	2020
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-14.30

FY	2020
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-14.30

FY	2019
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-112.74

FY	2018
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-111.67

Financial Reports:

No articles found.

Intec Pharma Ltd

Intec Pharma Ltd, a clinical stage biopharmaceutical company, focuses on developing drugs based on its proprietary Accordion Pill platform technology in Israel. Its Accordion Pill is an oral drug delivery system that is designed to enhance the efficacy and safety of existing drugs and drugs in development by utilizing a gastric retention and specific release mechanism. The company's lead product candidate is Accordion Pill Carbidopa/Levodopa, which is in a Phase III clinical trial for the treatment of Parkinson's disease symptoms in advanced Parkinson's disease patients. It is also developing Accordion Pill Zaleplon that is in a Phase III clinical trial as a treatment for the induction and maintenance of sleep in patients suffering from insomnia; a product candidate, which has completed a Phase I clinical trial for the prevention and treatment of gastroduodenal and small bowel Nonsteroidal Anti-Inflammatory Drug induced ulcers; and AP-CBD/THC, AP-THC, and AP-CBD product candidates with Cannabidiol and 9-Tetrahydrocannabinol for the treatment of various pain indications. Intec Pharma Ltd. has a research collaboration agreement with Merck to explore using the Accordion Pill platform for development program. The company was formerly known as Intec Pharmaceuticals (2000) Ltd. and changed its name to Intec Pharma Ltd in March 2004. Intec Pharma Ltd was founded in 2000 and is based in Jerusalem, Israel.